Recce Pharmaceuticals Announces Update on Phase I/II Clinical Trial for the Treatment of Burn Wound Infections

NEXT STORY
Herborium® Announces 4th Quarter Update Record Black Friday and Cyber Monday Sales Bring 15% Revenue Growth in 4th Quarter and Expected Highest Yearly Revenues On Record.
PREV STORY
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Acetium® is used in a Japanese cancer study – according to Professor Katsunori Iijima, the product can be a significant way to prevent cancer

Biohit Oyj Press Release November 19, 2015 at 14:45 pm local time (EET) Professor ...

author_avatar
NASDAQ Market News

Ballad Health Reports Six-Month Results: Better Quality, Strong Financial Performance, and Significant Capital Investments

author_avatar
NASDAQ Market News

Global Drug Discovery Informatics Market – Driven By Growing R&D Expenditure, Rising Support For Research, Particularly In The Area Of Rare Diseases, And The Growing Use Of Informatics In Drug Discovery

author_avatar
NASDAQ Market News